Member Info for unhooked

Thank you, it's a helpful simplification.
Wouldn't we all take £3.95 a share, eh?
But putting it as a target isn't quite the same as getting there!
Even Kamani says "these are extremely ambitious targets in a changed world". Just a bit.

It's not odd because there's a 'trust' issue with this company - it really is as simple as that.
I don't say it with any relish because I'm a holder who knew about the reputational/sentiment risks of AWE, but thought they were well baked into a good purchase price with a margin of error...
Wrong! Turns out these issues were worse than I thought and they continue to linger like a bad smell in an airless room. The *only* way to open the window and dissipate the smell is to trade profitably and report said trading in a transparent way. Do that for a couple of updates and all will be well. Otherwise, it's a complete f up.

Misleasing reporting of this by Sharecast.
They're calling it a "Growth plan". No, it isn't - it's a recalibrated share incentive plan (albeit based on increases in market cap).
I'm not necessarily suggesting it's a bad idea, but goodness, let's at least describe it correctly!

Exasperation disguised as irony SB!

They're not very communicative are they? The last update was the Half Year Report released on 7th September 2022 when we were told that they were "well funded", with a $15.7m cash balance as at 30 June 2022. Goodness knows what the cash balance is now...Potentially we could be waiting until May for the Final Results to get more information.
I see that Trellus Health plc, the third leg in Harwood's rickety biotech stool, has also had a torrid week. If you superimpose the charts for RENX, VRCI and TRLS since 02/06/21, the earliest date available to include all 3, it's amazing how they've all ended up in exactly the same place today - all 90% down - although RENX has formed a slightly more encouraging 'bowl' giving the appearance of upward momentum.
Whatever. The only saving grace is that I never bought Trellus and thank god because my losses on RENX and VRCI (and EKF) have been bad enough.
All-in-all, it's been an unmitigated disaster!

With no discernible support it just keeps dropping...

Come on trade buyers, get your cheapo offers in and put us all out of our misery!!

Holding halved from around 10% to around 5%.
Bit weird to sell down here...

Market is very confused - and not just about Boohoo - US Treasury yields have been all over the place so far in 2023.

...downwards...and then down some more!
It appears there's little investor goodwill left - certainly I won't be averaging down and further biasing my portfolio towards its losers.

No, other than to say that the recent downward spiral is no more- lol.
A sharp 10% rise first thing yesterday morning, and up another 10% since then!
TR1s could be a-coming....

Weak hands which piggybacked on the recent Alliance/Frasers buys, now bailing in the absence of further buys I imagine.

I agree it's a dark cloud over the company - at least as regards sentiment - and sometimes, as these things roll on, more information comes to light in a process of 'discovery'... but, having read the article carefully (it's posted on the other share chat board) and seen the share price reaction, I'm not sure this is something to lose sleep over.
Never a dull moment with Dx. plc though.

I hope someone can cut & paste the Sunday Times article, or post a link behind the paywall.

Seems they're not going to shake off the ramifications of last year's corporate governance issue.
Oh dear.

Company appears to going through a tough patch. Anyone still onboard?

Well Silverblade, after EKF & RENX got pummelled, now it's VRCI's turn - down 10% today, but this time on no particular news I can find. They say bad things come in threes - certainly the case for those holding the C.Mills stable this week.

SB, I've always had a lingering worry that if they can't get the share price up to more reasonable levels, they might take it off public markets, saying it's for the benefit of shareholders as private markets will better support valuations and capital raising... I've seen exactly that reason being cited with a couple of other companies taken private recently. Needless to say, such an outcome will not be rewarding for holders, including me, who bought at significantly higher prices.

Silverblade, I think the latter (bolstering liquidity in anticipation of continued cash burn).
If it was in anticipation of a successful FDA outcome and subsequent price spike, why would they raise now at 90p? Surely they'd wait for the approval and then raise - that would be sensible and the normal way...
Perhaps they are 'insuring' themselves against the tail risk of FDA rejection, since a placement after that might be v difficult...?
Sorry, I don't have any answers...
Raising now is disappointing - it's telling me they don't see any positive catalysts coming by in the near future. Hope I'm wrong.

Wow, I got a buy quote under 90p just now.
Looks like I was too early coming back in last week...
These are all-time lows (or at least 10 years - that's as far back as my chart goes, lol) for this share...
Per the TU on 19/01/23, the company remains profitable and the debt is manageable... right?

Lol.
I'm putting my C.Mills dartboard back up!